Briefly speaking, TSG-6 and IL-1β expression levels were significantly increased in CDD patient tissues; and IL-1β treatment could significantly increase TSG-6 expression in HNPCs. This evidence concerns the gene IL1B and craniodiaphyseal dysplasia.